He has been involved with Apposite’s deals in multiple healthcare sub sectors and served on portfolio Boards in both the US and Europe. He has worked in deal-making in the healthcare sector since 2000 when he joined Deutsche Bank’s mergers and acquisitions practice, working with a number of multinational clients on corporate divestitures and acquisitions, including public takeovers and leveraged buy-outs. Sam then joined the Business Development team at Belgian pharmaceutical company, UCB, where he was instrumental in global product licensing and M&A, including UCB’s $2.7bn acquisition of the UK public biotech company, Celltech. Sam has a first degree in Natural Sciences and a masters degree in Chemistry from Cambridge University, as well as an MBA from Harvard Business School.